Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
04/2010
04/01/2010WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same
04/01/2010WO2010034319A1 Magnetite nanoparticles as a single dose treatment for iron deficiency anemia
04/01/2010WO2010034176A1 A throbin-like enzyme of agkistrodon acutus
04/01/2010WO2010002453A3 C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
04/01/2010WO2008139845A8 Novel amide derivative
04/01/2010US20100081810 C-Pyrazole A2A Receptor Agonists
04/01/2010US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products
04/01/2010US20100081793 Therapeutic uses of humanized antibodies against alpha-4 integrin
04/01/2010US20100081712 Recombinant human factor ix and use thereof
04/01/2010US20100081708 Anticoagulant compounds
04/01/2010US20100081694 Composition comprising at least one ppar agonist and a lipid component
04/01/2010US20100081685 Pharmaceutical composition
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100080851 Method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule
04/01/2010US20100080822 treating menstrual cramps by administering composition of extracts from stem of Cinnamomum cassia, sclerotium of Poria cocos, root bark of Paeonia suffruticosa, root of Paeonia lactiflora and seed of Prunus persica or Prunus davidiana; composition comprises1.3-1.9% Paeoniflorin and 0.7-1.1% Paeonol
04/01/2010US20100080788 Alginate and alginate lyase compositions and methods of use
04/01/2010CA2738285A1 Method for producing lipids
04/01/2010CA2738282A1 Method for concentrating lipids
04/01/2010CA2738147A1 Solid pharmaceutical composition
03/2010
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168588A1 An extract of rehmannia glutinasa libosch. for reducing blood sugar, reducing blood fat, treating leukemia and preparation method and uses thereof
03/31/2010EP2167657A2 Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma
03/31/2010EP2167500A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders
03/31/2010EP2167499A2 Substituted oxazolidinones and use thereof
03/31/2010EP2167495A1 Substituted oxazolidinones and the use thereof
03/31/2010EP2167132A1 Resuscitation fluid
03/31/2010EP2167117A1 Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders
03/31/2010EP2167079A1 Steroid-sparing methods of treating brain edema
03/31/2010EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
03/31/2010EP1301194B1 Essential oil combination and therapeutic uses thereof
03/31/2010EP1107989B1 Expression and export of angiostatin and endostatin as immunofusins
03/31/2010CN101687810A Bicyclic compound and pharmaceutical use thereof
03/31/2010CN101687805A Benzazepine derivatives useful as vasopressin antagonists
03/31/2010CN101687797A Malonamide derivatives with antithrombotic activity
03/31/2010CN101687015A Activin-actrii antagonists and uses for increasing red blood cell levels
03/31/2010CN101686959A Combination therapy with a compound acting as a platelet ADP receptor inhibitor
03/31/2010CN101684151A Protein matter with coagulation activity
03/31/2010CN101684124A Novel compound with blood coagulation resisting function
03/31/2010CN101683529A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
03/31/2010CN101683522A Novel albumin-free factor viii formulations
03/31/2010CN101683521A Human eryth ropoietin liposome
03/31/2010CN101683511A Ground lute formulation for treating dropsy
03/31/2010CN101683509A Traditional Chinese medicine preparation for liver protection and diuresis of fowls and preparation method thereof
03/31/2010CN101683507A Traditional Chinese medicine composition for supplementing qi and invigorating blood circulation
03/31/2010CN101683497A Preparation method of powder containing ginseng and frog ingredients
03/31/2010CN101683495A Skull formulation for treating dropsy
03/31/2010CN101683481A Kuh-seng formulation for treating nephritic dropsy
03/31/2010CN101683478A Traditional Chinese medicine composition for thrombolysis
03/31/2010CN101683450A Escargot formulation for treating dropsy
03/31/2010CN101683448A Method for preparing goat liver powder for producing blood and lessening virulence of any pathogenic organism
03/31/2010CN101683438A Morning glory formulation for treating nephritic dropsy
03/31/2010CN101683428A Traditional Chinese medicine composition with function of gore removing and vein relaxing
03/31/2010CN101683426A Pharmaceutical composition for preventing and treating dorking abdominal dropsy generated during later feeding period
03/31/2010CN101683425A Pharmaceutical composition for treating dorking abdominal dropsy caused by high natrium
03/31/2010CN101683419A Traditional Chinese medicine composition for cooling the blood and stopping the blood
03/31/2010CN101683390A Plantain seed formulation for treating dropsy
03/31/2010CN101683384A Desmodium formulation for treating nephritic dropsy
03/31/2010CN101683377A Croton cream formulation for treating dropsy
03/31/2010CN101683363A Composition preparation of ginkgo biloba extract and dipyridamole and preparation method thereof
03/31/2010CN101683099A Stone-removing detoxication health tea
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687516 Alcohol free formulation of argatroban
03/30/2010US7687479 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin
03/30/2010US7687476 administering 4-thiouridine, isomaltitol and uridine as antiinflammatory agents and/or problems in hemostasis related to platelet function
03/30/2010US7687457 Cyclic molecular framework and derivatives thereof
03/30/2010CA2436667C Novel bioactive substance
03/30/2010CA2423631C 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/25/2010WO2010031876A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments
03/25/2010WO2010007502A3 Platelet fraction deriving from placental blood
03/25/2010US20100074958 Methods and compositions for targeting fenestrated vasculature
03/25/2010US20100074938 Immobilised biological entities
03/25/2010US20100074927 Delivery of therapeutic compounds via microparticles or microbubbles
03/25/2010US20100074886 Ccr2 antagonists for treatment of fibrosis
03/25/2010US20100074872 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
03/25/2010DE69029370C5 Erythropoietin-Isoformen Erythropoietin isoforms
03/25/2010CA2738018A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments
03/24/2010EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells
03/24/2010EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof
03/24/2010EP2165711A1 Methods for treating bleeding disorders using sulfated polysaccharides
03/24/2010EP1813294B1 Adhesion preventive and method of preventing adhesion
03/24/2010EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
03/24/2010CN201426858Y Clopidogrel hydrogen shlfate and aspirin double-layer tablet
03/24/2010CN101679373A New solid forms of FXA inhibitors
03/24/2010CN101679309A Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
03/24/2010CN101679298A fused bicyclic heteroaryl derivatives
03/24/2010CN101678119A Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
03/24/2010CN101678110A Solid dialysis preparation
03/24/2010CN101678089A Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments
03/24/2010CN101678043A Composition for promoting ketone compound formation
03/24/2010CN101678031A Formulations containing triazinones and iron
03/24/2010CN101677958A Oral pharmaceutical preparation for colon-specific delivery
03/24/2010CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
03/24/2010CN101676298A 黑皮质素受体配体 Melanocortin receptor ligands
03/24/2010CN101675991A Liquid composition of modified factor vii polypeptides
03/24/2010CN101675989A Qi-supplementing, spleen-invigorating, kidney-tonifying and blood-generating traditional Chinese medicine composition
03/24/2010CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675925A Dimethylaminoethyl ginkgolide B mesylate injection and preparation method thereof
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 671